\
&
Contact us
\
&
Contact us
This was 1 year ago
Locationonline
ProgrammesOn the 26th of February Care4Bio and the Premiere project will organize a matchmaking event to find partners for calls for proposals within cluster 6 of Horizon Europe.
Care4Bio is notably the EU network of national contact points for cluster 6. The Premiere project is a Horizon Europe funded project that aims to strengthen the multi-actor approach by supporting the development of more relevant, coherent, and well-prepared project proposal. This event is linked to this webinar on the 27th of February
If you are looking for partners in an upcoming cluster 6 project or you would like to know more about other upcoming projects, this is the ideal place and moment. There is also a one hour timeslot where you can hold 1-to-1 meetings via videoconference. You can find all the details about the event on this website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
